Association between systemic anticoagulation and rate of intraocular hemorrhage following intravitreal anti-VEGF therapy for age-related macular degeneration

Ophthalmic Surgery Lasers and Imaging Retina

Volumn 44, Issue 5, 2013, Pages 455-459

  Olson, Joanna M ^a   Scott, Ingrid U ^a   Kerchner, Denise L ^a   Kunselman, Allen R ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; BEVACIZUMAB; CILOSTAZOL; CLOPIDOGREL; DIPYRIDAMOLE; FISH OIL; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; NONSTEROID ANTIINFLAMMATORY AGENT; PEGAPTANIB; PRASUGREL; RANIBIZUMAB; TICLOPIDINE; UBIDECARENONE; VASCULOTROPIN INHIBITOR; WARFARIN; ANGIOGENESIS INHIBITOR; ANTICOAGULANT AGENT; VASCULOTROPIN A; VASCULOTROPIN ANTIBODY;

ADULT; AGED; ANTICOAGULANT THERAPY; COMORBIDITY; CONFERENCE PAPER; CORRELATION ANALYSIS; DRUG SAFETY; DRUG UTILIZATION; FEMALE; HUMAN; INTRAOCULAR HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINA HEMORRHAGE; RETINA MACULA AGE RELATED DEGENERATION; RETROSPECTIVE STUDY; RISK FACTOR; SUBRETINAL HEMORRHAGE; VITREOUS HEMORRHAGE; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; INTRAVITREAL DRUG ADMINISTRATION; MIDDLE AGED; RETINA MACULA DEGENERATION; VERY ELDERLY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG USE; FOLLOW UP; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; MEDICAL RECORD REVIEW; PRESCRIPTION; SLIT LAMP; VISUAL ACUITY; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; MACULAR DEGENERATION;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTICOAGULANTS; EYE HEMORRHAGE; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETINAL HEMORRHAGE; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS HEMORRHAGE;

EID: 84884956021     PISSN: 23258160     EISSN: 23258179     Source Type: Journal    
DOI: 10.3928/23258160-20130909-06     Document Type: Conference Paper

References (25)

1. Bressler NM, Bressler SB, Fine SL Age-related macular degeneration. Surv Ophthalmol. 1988; 32(6): 375-413.
2. Klein R, Klein BE, Linton KL Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992; 99(6): 933-943.
3. Brown DM, Kaiser PK, Michels M, et al Ranibizumab versus verte-porfin for neovascular age-related macular degeneration. N Engl J Med. 2006; 355(14): 1432-1444. (Pubitemid 44511558)
4. Rosenfeld PJ, Brown DM, Heier J.S., et al Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006; 355(14): 1419-1431. (Pubitemid 44511557)
5. Stone E. A very effective treatment for neovascular macular degeneration. N Engl J Med. 2006; 355: 1493-1495. (Pubitemid 44511565)
6. Rosenfeld PJ, Rich RM, Lalwani GA Ranibizumab: Phase III clinical trial results. Ophthalmol Clin North Am. 2006; 19(3): 361-372. (Pubitemid 44279358)
7. Spaide R. Ranibizumab according to need: a treatment for age-related macular degeneration. Am J Ophthalmol. 2007; 143(4): 679-680. (Pubitemid 46452536)
8. Avery RL, Pieramici DJ, Rabena M.D., Castellarin AA, Nasir MA, Gi-ust MJ.Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration. Ophthalmology. 2006; 113(3): 363-372.e5
9. Fung AE, Rosenfeld PJ, Reichel E. The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol. 2006; 90(11): 1344-1349. (Pubitemid 44702055)
10. Mason JO, Frederick PA, Neimkin M.G., et al Incidence of hem-orrhagic complications after intravitreal bevacizumab (avastin) or ranibizumab (lucentis) injections on systemically anticoagulated patients. Retina. 2010; 30(9): 1386-1389.
11. Kiernan DF, Hariprasad SM, Rusu I.M., Mehta SV, Mieler W F, Jager RD Epidemiology of the association between anticoagulants and intraocular hemorrhage in patients with neovascular age-related macular degeneration. Retina. 2010; 30(10): 1573-1578.
12. Dayani PN, Siddiqi OK, Holekamp NM Safety of intravitreal injections in patients receiving warfarin anticoagulation. Am J Ophthalmol. 2007; 144(3): 451-453. (Pubitemid 47331391)
13. Loukopoulos V, Meier C, Gerding H. Hemorrhagic complications after intravitreal injections of ranibizumab in patients under coumarin-type anticoagulation. Klin Monbl Augenheilkd. 2010; 227(4): 289-291.
14. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. Arch Ophthalmol. 2001; 119(10): 1417-136.
15. Liang KY, Zeger SL Longitudinal data analysis using generalized linear models. Biometrika. 1986; 73(1): 13-22.
16. Tolentino M. Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease. Surv Ophthalmol. 2011; 56(2): 95-113.
17. Day S, Acquah K, Mruthyunjaya P., Grossman DS, Lee P P, Sloan FA Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration. Am J Ophthalmol. 2011; 152(2): 266-272.
18. Kaufman DW, Kelly J P, Rosenberg L, Anderson T.E., Mitchell AA Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002; 287(3): 337-344. (Pubitemid 34251967)
19. Kelly J.P., Kaufman DW, Kelley K, Rosenberg L., Anderson TE, Mitchell AA Recent trends in use of herbal and other natural products. Arch Intern Med. 2005; 165(3): 281-286. (Pubitemid 40216279)
20. Cho HJ, Shon YH, Nam KS Ginkgolide C inhibits platelet aggregation in cAMP- and cGMP-dependent manner by activating MMP-9. Biol Pharm Bull. 2007; 30(12): 2340-2344.
21. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med. 1997; 336(15): 1108. (Pubitemid 27163872)
22. Matthews MK Jr. Association of ginkgo biloba with intracerebral hemorrhage. Neurology. 1998; 50: 1933-1934.
23. Kaye A, Clarke R, Sabar R., Vig S. Herbal medicines: current trends in anesthesiology practice-a hospital survey. J Clin Anesth. 2000; 12(6): 468-471.
24. Fihn SD, McDonell M, Martin D., et al Risk factors for complications of chronic anticoagulation: a multicenter study. Ann Intern Med. 1993; 118(7): 511-520. (Pubitemid 23085793)
25. Martin D.F., Maguire MG, Ying G.S., Grunwald JE, Fine SL, Jaffe GJ Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration. N Engl J Med. 2011; 364(20): 1897-1908.